Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13 Year: 2004
Pharmacokinetics and pharmacodynamics of newer fluoroquinolones in patients with lower respiratory tract infections Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Telithromycin is as effective as comparator antibacterials in the treatment of lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 561s Year: 2002
Intrapulmonary penetration of antimicrobials and implications in treatment of lower respiratory tract infections Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009
Evaluation of antibiotics therapy for low respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 406s Year: 2007
Bacterial agents of community-acquired lower respiratory tract infections: observational study on antimicrobial drugs susceptibility Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines Source: Eur Respir J 2011; 37: 112-118 Year: 2011
Immunomodulatory effects of moxifloxacin in human respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Antibiotic switch therapy in lower respiratory tract infections Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009
Telithromycin is highly efficacious in the treatment of lower respiratory tract infections Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009
Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008
Influence of antibiotic resistance of pseudomonas aeruginosa on presenting features of community-acquired lower respiratory tract infections Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011
Lower respiratory tract infections: bacteria and virus, antibiotics and steroids Source: Annual Congress 2008 - Infection year in review Year: 2008
Efficacy and safety of Cefdinir in lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 420s Year: 2002
Treatment of respiratory tract infections: comparison of telithromycin and azithromycin Source: Eur Respir J 2004; 24: Suppl. 48, 638s Year: 2004
Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85 Source: Eur Respir Rev 2005; 14: 74-77 Year: 2005
Streptococcal resistance to antibiotics in children with upper respiratory tract infections. Epidemiological aspects Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology Year: 2010
Are antimicrobials still the future of respiratory infection therapy? Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021